Medicare limits coverage of controversial Alzheimer's drug to those in clinical trials - CNN
4/7/2022 12:00:00 AM3 years 10 months ago
by Tami Luhby, CNN
by Tami Luhby, CNN
Medicare will restrict coverage of the controversial and costly Alzheimer's drug Aduhelm to those enrolled in qualifying clinical trials, the Centers for Medicare and Medicaid Services announced Thursday.
(CNN)Medicare will restrict coverage of the controversial and costly Alzheimer's drug Aduhelm to those enrolled in qualifying clinical trials, the Centers for Medicare and Medicaid Services announced… [+5868 chars]
full article...